Profile data is unavailable for this security.
About the company
Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in the research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. The Company has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes. The Kamaptive is a seamless, intuitive integration of multi-modal energy sources. Its CROMA delivers bipolar radiofrequency (RF) energy for precise localized cutting and focused high frequency microwave (MW) energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.
- Revenue in GBP (TTM)2.20m
- Net income in GBP12.60m
- Incorporated2016
- Employees133.00
- LocationCreo Medical Group PLCUnit 2 Beaufort Park,, Beaufort Park WayCHEPSTOW NP16 5UHUnited KingdomGBR
- Phone+44 129 160 6005
- Websitehttps://creomedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abingdon Health PLC | 8.43m | -3.42m | 15.06m | 121.00 | -- | 2.19 | -- | 1.79 | -0.0176 | -0.0176 | 0.0435 | 0.0274 | 1.17 | 9.71 | 3.87 | 69,661.16 | -47.42 | -54.04 | -70.70 | -85.91 | 44.32 | 30.37 | -40.51 | -110.07 | 1.58 | -- | 0.1625 | -- | 37.39 | 9.99 | -168.69 | -- | -26.92 | -- |
| Inspiration Healthcare Group PLC | 45.20m | -11.44m | 15.24m | 214.00 | -- | 0.9312 | -- | 0.3372 | -0.1275 | -0.1275 | 0.5038 | 0.1826 | 1.03 | 2.00 | 5.91 | 211,215.00 | -25.96 | -6.05 | -33.03 | -7.45 | 44.39 | 46.62 | -25.32 | -7.01 | 1.11 | 2.42 | 0.441 | -- | 1.65 | 16.56 | -148.04 | -- | 39.05 | -- |
| Renalytix PLC | 2.19m | -14.90m | 25.20m | 45.00 | -- | -- | -- | 11.50 | -0.0594 | -0.0594 | 0.008 | -0.0154 | 0.4547 | 7.64 | 4.54 | -- | -309.18 | -83.70 | -- | -107.25 | 40.00 | 28.27 | -680.00 | -1,519.31 | 1.17 | -24.57 | 6.38 | -- | 31.06 | -- | 55.14 | -- | -- | -- |
| Aptamer Group PLC | 1.20m | -2.42m | 25.62m | 31.00 | -- | 13.69 | -- | 21.30 | -0.0014 | -0.0014 | 0.0007 | 0.0007 | 0.4294 | 6.27 | 4.35 | 38,806.45 | -86.53 | -- | -154.00 | -- | 48.13 | -- | -201.50 | -- | 1.48 | -84.63 | 0.2622 | -- | 39.88 | -- | 18.05 | -- | -- | -- |
| Aoti Inc | 46.65m | 1.72m | 44.41m | 80.00 | 21.19 | 3.43 | 12.95 | 0.9519 | 0.0197 | 0.0197 | 0.4687 | 0.1219 | 1.32 | 2.17 | 4.65 | -- | 4.87 | -- | 6.54 | -- | 88.13 | -- | 3.69 | -- | 2.54 | 2.81 | 0.5269 | -- | 32.88 | -- | 78.55 | -- | -- | -- |
| Ondine Biomedical Inc | 1.19m | -12.88m | 46.80m | 43.00 | -- | 102.33 | -- | 39.42 | -0.0353 | -0.0353 | 0.0032 | 0.0009 | 0.3447 | 0.5771 | 8.03 | -- | -373.83 | -- | -4,807.85 | -- | 65.77 | -- | -1,084.66 | -- | 0.7948 | -- | 0.4333 | -- | 70.32 | -- | -32.51 | -- | -- | -- |
| Creo Medical Group PLC | 2.20m | 12.60m | 72.60m | 133.00 | 5.95 | 1.19 | 5.22 | 33.00 | 0.0296 | 0.0272 | 0.0056 | 0.1477 | 0.0319 | -0.8034 | 0.3308 | 16,541.35 | 18.25 | -29.25 | 20.62 | -35.89 | 45.45 | 47.22 | 572.73 | -176.82 | 4.75 | -69.50 | 0.0645 | -- | 0.00 | 212.28 | -17.30 | -- | -18.58 | -- |
| Inspecs Group PLC | 192.83m | -3.31m | 76.25m | 1.65k | -- | 0.8558 | 8.16 | 0.3954 | -0.0326 | -0.0806 | 1.90 | 0.8764 | 0.9138 | 2.31 | 7.71 | 116,586.50 | -1.57 | -2.16 | -2.31 | -3.13 | 51.86 | 49.60 | -1.72 | -2.79 | 0.8847 | 1.73 | 0.3969 | -- | -2.48 | 32.80 | -362.19 | -- | 4.97 | -- |
| SDI Group PLC | 69.29m | 4.59m | 85.75m | 504.00 | 19.07 | 1.67 | 9.46 | 1.24 | 0.043 | 0.043 | 0.6497 | 0.4923 | 0.7692 | -- | 5.78 | 137,484.10 | 5.12 | 7.08 | 5.81 | 8.87 | -- | 63.93 | 6.65 | 8.60 | 1.19 | 5.75 | 0.3363 | 0.00 | 0.5027 | 21.99 | -5.84 | 8.99 | 11.55 | -- |
| EKF Diagnostics Holdings PLC | 50.22m | 6.12m | 107.56m | 297.00 | 18.44 | 1.56 | 9.79 | 2.14 | 0.0135 | 0.0135 | 0.1109 | 0.1597 | 0.6209 | 3.16 | 7.34 | 165,745.90 | 7.98 | 5.79 | 8.77 | 6.76 | 49.79 | 49.42 | 12.86 | 8.62 | 3.47 | -- | 0.0152 | -- | -4.59 | 2.25 | 165.39 | 11.16 | 3.02 | -- |
| Tristel Plc | 46.46m | 6.64m | 204.32m | 265.00 | 30.88 | 6.18 | 21.64 | 4.40 | 0.1383 | 0.1383 | 0.9676 | 0.6915 | 1.04 | 1.93 | 5.81 | 175,328.30 | 14.85 | 9.60 | 17.57 | 11.09 | 80.62 | 80.90 | 14.29 | 11.04 | 2.96 | -- | 0.1512 | 120.71 | 10.80 | 7.96 | 2.33 | 5.42 | -3.59 | 18.10 |
Data as of Feb 10 2026. Currency figures normalised to Creo Medical Group PLC's reporting currency: UK Pound GBX
39.26%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| M&G Investment Management Ltd.as of 31 Oct 2025 | 51.23m | 12.42% |
| Canaccord Genuity Wealth Ltd.as of 31 Dec 2024 | 36.17m | 8.77% |
| River Global Investors LLPas of 31 Mar 2025 | 20.83m | 5.05% |
| AXA Investment Managers UK Ltd.as of 31 Dec 2025 | 14.50m | 3.52% |
| Baillie Gifford & Co.as of 31 Jan 2026 | 10.00m | 2.42% |
| Amati Global Investors Ltd.as of 31 Oct 2025 | 6.62m | 1.60% |
| BlackRock Investment Management (UK) Ltd.as of 30 Sep 2025 | 6.55m | 1.59% |
| Chelverton Asset Management Ltd.as of 30 Jun 2025 | 6.17m | 1.50% |
| Octopus Investments Ltd.as of 30 Jan 2026 | 4.95m | 1.20% |
| Border to Coast Pensions Partnership Ltd.as of 31 Mar 2025 | 4.93m | 1.20% |
More ▼
Data from 30 Sep 2025 - 30 Jan 2026Source: FactSet Research Systems Inc.
